Tigecycline
| Catalogue No. : |
C14262 |
| Product Name: |
Tigecycline |
| Synonym: |
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)- (9CI); Glycylcycline;Tygacil, GAR-936, WAY-GAR-936, TBG-MINO |
| Chemical Name: |
(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[(tert-butylamino)acetamido]-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-carboxamide |
| CAS No. : |
220620-09-7 |
| Structure : |
|
| Molecular Formula: |
C29H39N5O8 |
| Molecular Weight: |
585.65 |
| Appearance: |
Orange powder |
| Solubility: |
DMSO≥117mg/mL Wate≥117mg/mL Ethanol<1mg/mL |
| Purity: |
>98%,>99% |
| Usage: |
Tigecycline is a glycylcycline antibiotic. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus and acinetobacter baumanii. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
